Overview
DUTCH Sex Hormone Metabolites provides a comprehensive profile of sex hormone metabolites derived from dried urine samples, analysed using advanced GC-MS/MS technology. This method focuses on the measurement of oestrogen, progesterone, and androgen metabolites, with results adjusted for creatinine levels to approximate 24-hour urine output without the need for multiple collections. Such detailed profiling offers insight into the body’s hormone metabolism over time rather than a single static measurement. The analysis supports understanding patterns related to hormone production and metabolite balance.
This approach offers valuable information for those interested in exploring hormone metabolism in relation to general wellbeing factors such as mood, energy regulation, body composition, or reproductive life phases. Practitioners may integrate test results with personal history, age, sex, menstrual cycle status, lifestyle habits, and relevant laboratory data. Interpreting these patterns within a broader context can assist in tracking changes or supporting wellness discussions. The test is suited for baseline evaluations or periodic assessments depending on individual preferences.
By providing a detailed breakdown of sex hormone metabolites, DUTCH Sex Hormone Metabolites enables an enhanced view of hormonal activity that goes beyond conventional single-point hormone levels. This test can complement wider health and lifestyle assessments by contributing data-driven insights into hormone metabolism. It is particularly useful for those seeking to understand individual hormone-related trends and balance over time in a non-clinical setting.
DUTCH Sex Hormone Metabolites is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. DUTCH Sex Hormone Metabolites is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.
Practical
Downloads
02-Jun-2026